STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
GBT GLOBAL BLOOD THERAPEUTICS INCORPORATED StockScouter® Report
2
StockScouter® Score
GLOBAL BLOOD THERAPEUTICS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
F
F
A